McAlevey Michael R reported other involving 7,769 shares of HCA Healthcare, Inc. at $429.00 for −$3.33M on Aug 26, 2026

Other
Form 4 code J. Other acquisition or disposition. The filer must describe the transaction.
EVP & Chief Legal & Admin Off.
EVP & Chief Legal & Admin Off.
Filed Aug 28, 2026

Facts from the filing

Form 4 · Non-derivative, table I
Disclosed value
−$3,332,901Shares × reported price
Shares traded
7,769Common Stock
Price per share
$429.00Reported price. Read footnotes for ranges.
% of reported position traded
UnavailableThis security and ownership context
Holdings after
0Indirect · By 2026 GRAT
Trade date
Aug 26, 2026Other
Filed
Aug 28, 2026, 5:00 PM ET2-day reporting delay
Accession
0001193125-26-374693Code J · Transaction 118091
How reported position traded is calculated

Calculated only for code-P purchases and code-S sales.

Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.

Other trades in this filing

Related trades are temporarily unavailable. Open the SEC filing for the complete report, or reload this page.

Filing warnings

Notes recorded with this filing
1 warning
ambiguous transaction codeThe transaction code is missing or represents other activity; review the filing and footnotes.

HCA price since this filing

Daily closing prices, with the filing date and available return windows. Return methodology
HCA · Daily closing priceDaily price data is pending. The chart appears when valid daily closes are available.
Filing dateReturn windows appear as prices become available.
Pre-filing1mo ago −6.7%1w ago −2.6%1d ago +2.3%
Returns since7d −3.1%30d +4.3%90d180d1y

Footnotes in full

F1: Pursuant to a power of substitution, on August 26, 2026, the Reporting Person transferred 7,769 shares of common stock of the Issuer from a trust to direct ownership in exchange for assets of equal value. The transfer was made at a price per share equal to $429.00 (the average of the high and low prices of shares of common stock of the Issuer on August 26, 2026). The transfer did not change the total number of shares of common stock of the Issuer of which the Reporting Person may be deemed to have beneficial ownership; however, the shares of common stock previously have been reported by the Reporting Person as indirectly owned. The Reporting Person believes that the transfer of shares from the trust constitutes a change in form of beneficial ownership of such shares, exempted by Rule 16a-13 under the Securities Exchange Act of 1934. Subsequently, on August 26, 2026, the Reporting Person transferred 7,769 shares of common stock of the Issuer from direct ownership to a trust. F2: The shares reported herein are held in a fully managed account over which the Reporting Person does not have any investment authority. The Reporting Person disclaims beneficial ownership of the shares reported herein except to the extent of his pecuniary interest therein.